AKYA
$3.9
Revenue | $26.49Mn |
Net Profits | $-10.8Mn |
Net Profit Margins | -40.78% |
Akoya Biosciences Inc’s revenue jumped 24.83% since last year same period to $26.49Mn in the Q4 2023. On a quarterly growth basis, Akoya Biosciences Inc has generated 5.04% jump in its revenue since last 3-months.
Akoya Biosciences Inc’s net profit jumped 42.77% since last year same period to $-10.8Mn in the Q4 2023. On a quarterly growth basis, Akoya Biosciences Inc has generated 16.37% jump in its net profits since last 3-months.
Akoya Biosciences Inc’s net profit margin jumped 54.15% since last year same period to -40.78% in the Q4 2023. On a quarterly growth basis, Akoya Biosciences Inc has generated 20.38% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.29 |
EPS Estimate Current Year | -0.29 |
Akoya Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.29 - a -7.41% fall from last quarter’s estimates.
Akoya Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.29.
Earning Per Share (EPS) | -0.22 |
Return on Assets (ROA) | -0.2 |
Return on Equity (ROE) | -1.13 |
Akoya Biosciences Inc’s earning per share (EPS) jumped 56% since last year same period to -0.22 in the Q4 2023. This indicates that the Akoya Biosciences Inc has generated 56% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Akoya Biosciences Inc’s return on assets (ROA) stands at -0.2.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Akoya Biosciences Inc’s return on equity (ROE) stands at -1.13.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-03-05 | -0.27 | -0.22 | 18.52% |
2023-05-09 | -0.48 | -0.49 | -2.08% |
2023-11-09 | -0.37 | -0.26 | 29.73% |
2023-08-08 | -0.44 | -0.46 | -4.55% |